Hidden Triggers Cause Severe Allergic Reactions
Patients on compounded weight-loss drugs or venom allergy shots may face reactions that medication history and careful screening can help identify.
Updated on Nov. 20, 2026 in Diabetes

Case reports presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Meeting describe three unusual allergic reactions: a surgical anaphylactic shock traced to a chlorhexidine-coated catheter, reactions after switching compounded weight-loss medications, and anaphylaxis during long-running honeybee venom immunotherapy. The cases are individual reports, not population-level findings, and they point to hidden triggers that clinicians and patients may not expect.
Why it matters
Patients on compounded GLP-1 medications and those receiving allergy shots are the groups most directly affected, and each case shows a reaction that can be missed without a careful medication and exposure history. The reports arrive as obesity drugs are widely prescribed and compounded versions are used outside standard approval pathways, making medication switches and product-level differences a practical concern.
These are three individual case reports presented at the ACAAI 2026 Annual Meeting, not a controlled study, so they cannot show how common these reactions are. Each case documents a specific clinical sequence, and the reports identify the suspected triggers through diagnostic testing and clinical course.
The players
American College of Allergy, Asthma and Immunology (ACAAI)
The professional medical society for allergists and immunologists, which hosted the 2026 Annual Meeting where these case reports were presented.
Mayo Clinic
A major academic medical center in Jacksonville, Florida, with a large clinical allergy and immunology practice, whose clinicians authored one of the GLP-1 case reports.
Lowell General Hospital
A community hospital in Lowell, Massachusetts, where the chlorhexidine-related surgical case occurred.
The details
In the first case, a chlorhexidine-coated central venous catheter was placed during surgery, and the surgical team had not recognized the coating; the patient's chlorhexidine allergy was confirmed by testing. In a rescheduled surgery, clinicians used povidone-iodine for skin preparation, but symptoms still recurred after the catheter was placed. In the second case, a patient whose weight loss had plateaued switched from compounded semaglutide to compounded tirzepatide and developed recurrent reactions, including injection-site urticaria, that escalated over 8 days on rechallenge. In the third case, a patient maintaining honeybee venom immunotherapy developed anaphylaxis after menopause onset, and the therapy was discontinued after three grade 4 episodes.
Timeline
After a year on compounded semaglutide, the second patient switched to compounded tirzepatide.
Over 8 days, escalating reactions occurred during the tirzepatide rechallenge.
Symptoms developed within 2 minutes of catheter placement in the first case.
Anaphylaxis with venom maintenance injections began following the onset of menopause in the third case.
High-dose corticosteroids were tapered over 6 weeks to treat the GLP-1 reaction.
Health Landscape
The reports add clinical detail to ongoing concern about compounded semaglutide and tirzepatide, which have been prescribed widely outside the manufacturer-approved formulations. They also show that allergy and immunotherapy specialists are encountering reactions that depend on excipients, antiseptics and medication history rather than on a single known allergen.
If you are taking a compounded GLP-1 medication and have had an unexpected reaction after switching products, it is worth raising the change with your prescriber. Anyone receiving allergy injections who develops new symptoms after a life change, such as menopause, should discuss this with their allergist.
The takeaway
Unexpected allergic reactions can come from ingredients that are not obvious, including surgical antiseptics and compounded medications. Keeping an accurate list of prior medications, switches and known allergies, and sharing it with every care team, helps clinicians identify these triggers sooner.
Further reading
For more on how these medications are used in managing blood sugar and weight, see our Diabetes coverage.
Source note: This article includes information reported by Medscape.





